← All stocks

Labcorp

LH Net selling
CIK 0000920148 #284 in the set updated 17 Sep 2026
Bought (120 mo)
$1.04M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$175.44M
$18.90M on a plan · $105.33M straight out of an exercise
Sold at will
$51.21M
114 of 210 sales
Net
−$174.40M
−$50.17M against sales at will

By person

36 insiders · 219 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
KING DAVID P
Director
$63.14M (15) scheduled
−$63.14M
344,155
0.4244%
$109.45M
+77.8%
EISENBERG GLENN A
Executive Vice President
$34.20M (27) scheduled
−$34.20M
37,920
0.0468%
$12.06M
+358.6%
Schechter Adam H
President & CEO
$14.69M (10) scheduled
−$14.69M
102,565
0.1265%
$32.62M
+2,192%
van der Vaart Sandra D
EVP, Corporate Affairs
$8.53M (33) scheduled
−$8.53M
6,239
0.0077%
$1.98M
+368.6%
ANDERSON KERRII B
Director
$7.56M (19) scheduled
−$7.56M
6,563
0.0081%
$2.09M
−62.5%
Schroeder Mark S
EVP, Pres Diagnostics & COO
$7.42M (22) scheduled
−$7.42M
12,677
0.0156%
$4.03M
+1,951%
BELINGARD JEAN-LUC
Director
$6.41M (4) scheduled
−$6.41M
17,781
0.0219%
$5.65M
−41.8%
BERBERIAN LANCE
EVP, Special Advisor, Strategy
$5.28M (6)
−$5.28M
18,652
0.0230%
$5.93M
+1,436%
EBERTS F SAMUEL III
Chief Legal Officer, Secretary
$4.89M (1) scheduled
−$4.89M
28,823
0.0355%
$9.17M
+59.5%
Kirchgraber Paul R
CEO, Covance Drug Development
$3.95M (4) scheduled
−$3.95M
12,946
0.0160%
$4.12M
+193.8%
Wilkinson Peter J
SVP, Chief Accounting Officer
$3.73M (15) scheduled
−$3.73M
1,770
0.0022%
$562.97K
+1,270%
Dodson Edward T
Principal Accounting Officer
$2.84M (3) scheduled
−$2.84M
13,663
0.0168%
$4.35M
+311.3%
Uthgenannt Lisa J
Chief Human Resources Officer
$2.69M (4)
−$2.69M
4,660
0.0057%
$1.48M
+23.3%
Summy Amy B.
EVP, Chief Marketing Officer
$2.27M (7) scheduled
−$2.27M
6,956
0.0086%
$2.21M
Parham Richelle P
Director
$1.78M (1)
−$1.78M
3,366
0.0042%
$1.07M
Williams R Sanders
Director
$1.47M (11)
−$1.47M
8,120
0.0100%
$2.58M
+50.0%
MITTELSTAEDT ROBERT E JR
Director
$1.37M (6) scheduled
−$1.37M
15,515
0.0191%
$4.93M
+36.7%
Gilliland Dwight Gary
Director
$1.30M (11)
−$1.30M
6,656
0.0082%
$2.12M
+128.6%
NEUPERT PETER M
Director
$922.82K (3)
+$922.82K
13,784
0.0170%
$4.38M
Caveney Brian J
EVP, Pres of BLS, CMO & CSO
$20.42K (2)
$923.46K (2)
−$903.03K
36,492
0.0450%
$11.61M
+3,767%
Meltzer Jonathan C
EVP, COO
$298.76K (4) scheduled
−$298.76K
3,620
0.0045%
$1.15M
+43.8%
Gary M. Huff
CEO, LabCorp Diagnostics
$293.82K (1)
−$293.82K
1,850
0.0023%
$588.21K
+359.4%
Kyle Kathryn W
EVP, Chief Legal Officer
$227.41K (2) scheduled
−$227.41K
3,904
0.0048%
$1.24M
+27.9%
DiVincenzo Jonathan P.
EVP, Pres, Central Labs & Intl
$107.75K (1)
−$107.75K
5,461
0.0067%
$1.74M
+65.0%
Seltz Judith C
EVP, CHRO
$99.36K (2)
+$99.36K
4,182
0.0052%
$1.33M
+1,075%
Vaughn Bryan T
EVP and President, Diagnostics
$66.97K (1) scheduled
−$66.97K
6,746
0.0083%
$2.15M
+31.1%
Ratliff John D
CEO, Covance Drug Development
16,941
0.0209%
$5.39M
Kong Garheng
Director
13,739
0.0169%
$4.37M
+308.4%
Davis Jeffrey A.
Director
5,460
0.0067%
$1.74M
GRAHAM ANITA Z
EVP, CHRO
5,185
0.0064%
$1.65M
+17,183%
Oyegunwa Akinbolade
EVP, CIO & CTO
5,064
0.0062%
$1.61M
+89.9%
Bailey Megan D.
EVP, Pres, Central Labs & Intl
4,851
0.0060%
$1.54M
+3,876%
Wengel Kathryn E
Director
4,133
0.0051%
$1.31M
Kliphouse Kirsten Marie
Director
3,160
0.0039%
$1.00M
Rothman Paul
Director
2,571
0.0032%
$817.63K
+19,677%
Wang Julia Aijun
Chief Financial Officer, EVP
1,817
0.0022%
$577.92K
+29,027%
Insider
Date
Role
Action
Shares
Price
Amount
ANDERSON KERRII B
17 Aug 2026
Director
Sold on a plan
3,000
$318.02
$954.06K
Schechter Adam H
11 Aug 2026
President & CEO
Sold on a plan
4,669
$320.37
$1.50M
Vaughn Bryan T
2 Jul 2026
EVP and President, Diagnostics
Sold on a plan
234
$286.19
$66.97K
Kyle Kathryn W
2 Jul 2026
EVP, Chief Legal Officer
Sold on a plan
92
$286.19
$26.33K
Kyle Kathryn W
8 Jun 2026
EVP, Chief Legal Officer
Sold on a plan
762
$263.89
$201.08K
Schechter Adam H
11 May 2026
President & CEO
Sold on a plan
5,903
$254.50
$1.50M
Meltzer Jonathan C
27 Mar 2026
EVP, Operations
Sold on a plan
839
$267.05
$224.05K
Wilkinson Peter J
27 Mar 2026
SVP, Chief Accounting Officer
Sold on a plan
1,633
$267.05
$436.09K
Wilkinson Peter J
19 Feb 2026
SVP, Chief Accounting Officer
Sold on a plan
666
$277.94
$185.11K
Meltzer Jonathan C
12 Feb 2026
EVP, Operations
Sold on a plan
87
$290.42
$25.27K
Meltzer Jonathan C
10 Feb 2026
EVP, Operations
Sold on a plan
91
$276.79
$25.19K
Meltzer Jonathan C
9 Feb 2026
EVP, Operations
Sold on a plan
88
$275.53
$24.25K
Schechter Adam H
11 Nov 2025
President & CEO
Sold on a plan
5,745
$262.75
$1.51M
Schechter Adam H
11 Aug 2025
President & CEO
Sold on a plan
5,643
$266.78
$1.51M
ANDERSON KERRII B
24 Jul 2025
Director
Sold on a plan
3,500
$280.00
$980.00K
ANDERSON KERRII B
24 Jul 2025
Director
Sold on a plan
3,500
$280.00
$980.00K
ANDERSON KERRII B
1 Jul 2025
Director
Sold on a plan
500
$265.00
$132.50K
Schechter Adam H
12 May 2025
President & CEO
Sold on a plan
6,105
$248.73
$1.52M
Schroeder Mark S
28 Mar 2025
EVP, Pres Diagnostics & COO
Sold on a plan
2,635
$231.67
$610.45K
Summy Amy B.
28 Mar 2025
EVP, Chief Marketing Officer
Sold on a plan
758
$231.67
$175.61K
Summy Amy B.
24 Feb 2025
EVP, Chief Marketing Officer
Sold on a plan
226
$250.40
$56.59K
ANDERSON KERRII B
7 Jan 2025
Director
Sold on a plan
1,000
$235.00
$235.00K
Schechter Adam H
11 Nov 2024
President & CEO
Sold on a plan
6,189
$243.47
$1.51M
ANDERSON KERRII B
24 Oct 2024
Director
Sold on a plan
1,000
$230.00
$230.00K
ANDERSON KERRII B
8 Aug 2024
Director
Sold on a plan
586
$225.00
$131.85K
ANDERSON KERRII B
7 Aug 2024
Director
Sold on a plan
414
$225.00
$93.15K
Summy Amy B.
1 Apr 2024
EVP, Chief Marketing Officer
Sold on a plan
3,500
$217.29
$760.52K
Schroeder Mark S
1 Apr 2024
EVP, Pres Diagnostics & COO
Sold on a plan
6,477
$217.29
$1.41M
van der Vaart Sandra D
28 Mar 2024
EVP, Chief Legal Officer
Sold on a plan
3,553
$216.74
$770.08K
Summy Amy B.
7 Mar 2024
EVP, Chief Marketing Officer
Sold on a plan
227
$218.45
$49.59K
van der Vaart Sandra D
13 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
237
$226.45
$53.67K
van der Vaart Sandra D
8 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
259
$222.06
$57.51K
van der Vaart Sandra D
5 Feb 2024
EVP, Chief Legal Officer
Sold on a plan
193
$220.57
$42.57K
van der Vaart Sandra D
29 Jun 2023
EVP, Chief Legal Officer
Sold on a plan
212
$240.00
$50.88K
Schroeder Mark S
31 Mar 2023
EVP, President-Diagnostics Lab
Sold on a plan
3,897
$225.81
$879.98K

What was left out

Form 4 filings counted 732
Amendments (4/A) skipped 2
Filings about a different issuer 1
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 35
Sales straight out of an exercise 61
Sales at will 114
Transactions with no price 0
Shares from compensation/vesting 2,552,387
Sales filed before the plan box existed 84
History held since 7 Sep 2016